Figshareopen access
Plain language summary: the evoke(+) studies of semaglutide for early Alzheimer’s disease
medicine, neuroscience, science policy, biological sciences not elsewhere classified, chemical sciences not elsewhere classified, semaglutide, alzheimer’s disease, evoke
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 205386
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.